NVO Competitors & Alternatives
Compare Novo Nordisk A/S with similar stocks in the same industry
Drug Manufacturers - General
NVO
Main Stock$40.65
Tradestie Score
41
Market Cap
$262.92B
P/E Ratio
10.4
Revenue Growth
0.1%
Analyst Upside
+12.7%
Top Competitors
20 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
UNH
UNITEDHEALTH GROUP INCORPORATED (Delaware)
|
$405.13
|
$315.45B | 23.0 | 59 | Compare |
|
AZN
AstraZeneca PLC
|
$184.38
|
$261.56B | 26.2 | 35 | Compare |
|
NVS
Novartis AG
|
$160.25
|
$254.99B | 30.6 | 36 | Compare |
|
MRK
Merck & Co., Inc.
|
$146.95
|
$225.13B | 148.7 | 54 | Compare |
|
AMGN
Amgen Inc
|
$467.06
|
$160.70B | 27.1 | 39 | Compare |
|
PFE
Pfizer Inc.
|
$28.83
|
$154.70B | 42.1 | 54 | Compare |
|
GILD
Gilead Sciences Inc
|
$167.95
|
$137.92B | - | 45 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$48.46
|
$121.27B | 24.1 | 29 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$62.32
|
$96.54B | 13.9 | 46 | Compare |
|
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
|
$50.64
|
$91.59B | 17.6 | 41 | Compare |
More NVO Analysis
Data updated: Nov 12, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
20 stocks in this industry